Brusamolino, Ercole <br/><br/>
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.  [electronic resource] 

 -  Haematologica  Apr 2006 
 - 496-502 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--complications<br/>Middle Aged<br/>Polyethylene Glycols<br/>Prednisone--administration & dosage<br/>Recombinant Proteins<br/>Rituximab<br/>Treatment Outcome<br/>Vincristine--administration & dosage